Diabetic cardiomyopathy: insights into pathogenesis, diagnostic challenges, and therapeutic options.
about
Cardiovascular Action of Insulin in Health and Disease: Endothelial L-Arginine Transport and Cardiac Voltage-Dependent Potassium ChannelsDiabetic Cardiomyopathy; Summary of 41 YearsDiabetic cardiomyopathy: bench to bedsideCongestive heart failure and diabetes mellitus: balancing glycemic control with heart failure improvementImmunoproteasomes: structure, function, and antigen presentationDiabetic cardiomyopathy: signaling defects and therapeutic approachesSitagliptin reduces cardiac apoptosis, hypertrophy and fibrosis primarily by insulin-dependent mechanisms in experimental type-II diabetes. Potential roles of GLP-1 isoformsDiagnostic approaches for diabetic cardiomyopathy.Subclinical Alterations of Cardiac Mechanics Present Early in the Course of Pediatric Type 1 Diabetes Mellitus: A Prospective Blinded Speckle Tracking Stress Echocardiography Study.Diabetic cardiomyopathy: pathophysiology and clinical featuresDiabetes is associated with impaired myocardial performance in patients without significant coronary artery disease.Flos Puerariae extract prevents myocardial apoptosis via attenuation oxidative stress in streptozotocin-induced diabetic mice.Diabetic cardiomyopathy: where we are and where we are going.Diabetes-induced alterations in the extracellular matrix and their impact on myocardial function.The prevalence of diabetic cardiomyopathy: a population-based study in Olmsted County, Minnesota.Association of glucose metabolism with diastolic function along the diabetic continuumEvidence for a role of immunoproteasomes in regulating cardiac muscle mass in diabetic miceChanges of myocardial lipidomics profiling in a rat model of diabetic cardiomyopathy using UPLC/Q-TOF/MS analysis.Mitochondria in monocytes and macrophages-implications for translational and basic researchStem cells as a therapeutic target for diabetes.Diabetic cardiomyopathy, causes and effects.Angiotensin II mediates the high-glucose-induced endothelial-to-mesenchymal transition in human aortic endothelial cells.Ischemia-reperfusion injury leads to distinct temporal cardiac remodeling in normal versus diabetic miceMicrotopographical cues in 3D attenuate fibrotic phenotype and extracellular matrix deposition: implications for tissue regenerationShort-term hyperinsulinemia and hyperglycemia increase myocardial lipid content in normal subjectsDiabetic cardiomyopathy: from the pathophysiology of the cardiac myocytes to current diagnosis and management strategiesChanges in left ventricular relaxation after azelnidipine treatment in hypertensive patients with diabetes: subanalysis of a prospective single-arm multicentre study.Diabetes alters intracellular calcium transients in cardiac endothelial cells.Eplerenone attenuated cardiac steatosis, apoptosis and diastolic dysfunction in experimental type-II diabetesEarly diagnosis of left ventricular diastolic dysfunction in diabetic patients: a possible role for natriuretic peptides.Noncardiac comorbidities in heart failure with reduced versus preserved ejection fractionMyocardial remodeling in diabetic cardiomyopathy associated with cardiac mast cell activation.Mice long-term high-fat diet feeding recapitulates human cardiovascular alterations: an animal model to study the early phases of diabetic cardiomyopathyThe role of oxidative stress in high glucose-induced apoptosis in neonatal rat cardiomyocytes.Changes in cardiac heparan sulfate proteoglycan expression and streptozotocin-induced diastolic dysfunction in ratsMRI-based strain and strain rate analysis of left ventricle: a modified hierarchical transformation model.The ECG vertigo in diabetes and cardiac autonomic neuropathy.Relationship between glycemic control and readmission rates in patients hospitalized with congestive heart failure during implementation of hospital-wide initiatives.Cardiac insulin resistance and microRNA modulators.Hyperpolarized magnetic resonance: a novel technique for the in vivo assessment of cardiovascular disease.
P2860
Q26751133-5381F22C-6252-4BB4-B932-1146F39C761CQ26799318-7A50C1DB-3E61-4965-9D6A-BC5D5BB702C9Q26997062-681AA226-3F37-4E21-AC51-93043ECB211BQ27003819-4F5310F6-9921-4CCF-B74E-07C1F20975DFQ27024527-B40718B3-5844-436E-AF68-A8B42426C0DBQ28395852-71F4F1AD-D61E-4C3F-9C80-23CC52896A7DQ28535415-D44FE332-48C7-4AFF-A62B-8F52170DB140Q30362092-27DA4398-D78D-449B-B234-6CF05CC2F654Q30391941-0E17E4D2-31AA-4222-A011-B09C1F78029DQ30457504-FFC713FC-9987-4A3A-9498-181CABD82144Q30483398-1BFC1965-A035-47E9-8AA9-4FA27CCFD595Q33670665-19F14539-B34A-4C93-8F51-A0CA99D0FB59Q33690717-54243925-D28D-4CB4-8AC9-9BBAA72AA1F9Q33711031-0D721962-5B92-48AF-B555-59970D31B1B9Q33825297-F275D5E6-A90B-4017-AAA5-7B57273896D9Q33880289-F3762D60-C1B3-4910-BBCB-AA1C94C49263Q33905980-36C852FC-3E2D-4154-B51D-7288084CBC9BQ33921629-0086652B-0C94-48E4-807C-93CB7CB9E3CAQ33954232-DD5DABFE-E514-47BA-94DF-316E0A8F7C74Q33982394-32E3AED0-0294-4023-B4B4-E5545C921AA6Q34038623-4D61FB94-597D-4B74-ACCB-6D9DB3FB2C54Q34060789-499A2CB5-5D3F-45B2-9CA9-FB40A6E9B9D5Q34162518-E1C6EAC0-C69D-465F-A501-D98F47BDACCCQ34163211-D0DBC280-520B-4742-962D-4AB8C4F2AA39Q34186806-C896A2DC-1E83-45B8-8898-64EB5A8257ECQ34245190-5A150D28-C1A9-49F4-98C0-61747AF252C9Q34264312-4A02006E-544A-47CB-81AC-85F87F36240CQ34271053-D74920FC-1227-467A-B95D-6A3B0A3E1913Q34464759-CD284A5E-A378-41C6-A42F-D8C04BE6188BQ34481884-ECA493D0-568A-4801-AAAD-EE39CCC6994DQ34625223-6CBD93FB-5582-46F1-91E0-61EB73CF3B3EQ34654120-D1225E3D-F5B2-4ADC-B2BE-36A61FCB80B8Q34674362-12C3244B-E63C-4200-915A-9633EE0AFC37Q34779954-E828AD13-E70A-4211-8348-570DBB8EDCCDQ34999815-BAE9A6BA-71E1-4CCB-A608-1AFE0EDA9905Q35011914-BFDE2144-3657-4FA1-A506-177AF1AB22C4Q35071142-6D28D4FD-39C1-462C-88BE-4E113C31FB94Q35126000-9109D750-5AC3-4CA9-9C6D-F9BFC5D17BDFQ35251097-E65433CC-70D8-4B79-850F-E091F152863EQ35298233-7B6B946D-C2FE-4834-8264-066068D9181B
P2860
Diabetic cardiomyopathy: insights into pathogenesis, diagnostic challenges, and therapeutic options.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Diabetic cardiomyopathy: insig ...... nges, and therapeutic options.
@en
Diabetic cardiomyopathy: insig ...... nges, and therapeutic options.
@nl
type
label
Diabetic cardiomyopathy: insig ...... nges, and therapeutic options.
@en
Diabetic cardiomyopathy: insig ...... nges, and therapeutic options.
@nl
prefLabel
Diabetic cardiomyopathy: insig ...... nges, and therapeutic options.
@en
Diabetic cardiomyopathy: insig ...... nges, and therapeutic options.
@nl
P2093
P1476
Diabetic cardiomyopathy: insig ...... nges, and therapeutic options.
@en
P2093
Ashish Aneja
Mario J Garcia
Michael E Farkouh
Sameer Bansilal
W H Wilson Tang
P304
P356
10.1016/J.AMJMED.2008.03.046
P407
P577
2008-09-01T00:00:00Z